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INTRODUCTION
Poor vision has long been recognized as a potential risk factor for fractures in older people. [1] [2] [3] [4] Previously, we reported on findings from the Study of Osteoporotic Fractures (SOF) that visual impairment as measured by depth perception and contrast sensitivity was associated with an elevated risk of hip fractures 5 and that decreased visual acuity was associated with an elevated risk of wrist fractures in older women. 6 Another readily available clinical measure is the evaluation of central and peripheral vision. Such vision is measured by testing for visual field deficits. In visual field testing, patients indicate when they perceive objects or points of light presented in different locations associated with central and peripheral vision. In automated visual field testing, this information is translated into pixels showing a map of the areas in the eye where perception occurs. Visual field loss is a measure of decreased or no perception of light across one or more pixels. Visual field measurement is a standard diagnostic tool for disorders within the visual pathway from the photoreceptor cells in the retina to the occipital lobe. Studies have reported a prevalence of visual field loss ranging from 5.6% to 17% in adults 40 years and older. 7, 8 Recently, we reported that binocular visual field (BVF) loss was associated with an increased risk of frequent falls in older white women. 9 In the limited research conducted, longitudinal studies have reported conflicting results on the link between visual field loss and the risk of hip fractures. 8, 10 One study reported that older whites with visual field loss did not have a higher risk of hip fracture, 8 while another investigation found that the relationship between visual field loss and hip fractures in whites waned with increasing follow-up time since the clinical exam. 10 Another prior study failed to find an association between visual field loss and wrist fractures in whites. 11 To test the hypothesis that BVF loss is an independent risk factor for fracture, we performed a comprehensive eye examination including visual field testing in a cohort of 4773 older women enrolled in SOF [12] [13] [14] and followed them prospectively for eight years.
METHODS

Subjects
From 1986 to 1988, 9,704 ambulatory white female volunteers who were 65 years or older, ambulatory with no history of bilateral hip replacement, were enrolled in SOF, a multicenter, prospective longitudinal cohort study for identifying potential risk factors of osteoporotic fractures, which has been described previously [12] [13] [14] . Beginning in January 1997, and continuing through September, 1998, all surviving participants were invited to participate in a follow-up clinical examination (6 th clinic visit, or V6), which included a comprehensive eye examination. In addition, a cohort of 662 women who identified themselves as African-Americans were recruited from population listings at each of the four clinic centers to participate in SOF and the eye examination. The same recruitment strategy was used to recruit both African-Americans and whites. The two cohorts have been pooled in a prior SOF manuscript. 12 All individuals in the study gave informed consent to participate. Institutional Review Board approvals were obtained from all participating institutions. A total of 5,482 women, including 662 African-American and 4,820 white participants, attended the 6 th clinic visit (V6). This sample of white women represented 63% of the surviving cohort. Our analyses excluded 552 women who did not have visual field tests in both eyes. They also excluded 157 women who had unreliable visual field tests (i.e. tests with fixation losses of 33% or higher in both eyes), leaving a final sample of 4,773 women (87% of those with a clinic visit permitting visual field testing) ( Figure 1 ). Visual field testing could not be carried out in participants who were unable to attend the clinicbased examinations.
Ascertainment of Fractures
All participants were contacted by postcard or telephone approximately every four months from September 1997 to April 2008 to determine whether they had a new fracture after V6. There has been a cumulative completion rate of 98% for these contacts since the inception of SOF. 14 To distinguish clearly between fracture and non-fracture cases, we excluded cases with reports of fractures that were not confirmed by x-ray records. Separate analyses were conducted for incident hip fractures and incident non-spine/non-hip fractures. A total of 4,583 women were included in the analysis of hip fractures, and after separating out hip and spine fractures, 3,869 women were included in the non-spine/non-hip fractures analysis ( Figure 1 ).
Assessment of Vision
Visual field tests were performed on each eye of a participant with the Humphrey Field Analyzer suprathreshold 76-point 30 ° visual field program (Humphrey Field Analyzer; Zeiss, Oberkochen, Germany). 15, 16 The suprathreshold 76-point program is a screening visual field test measuring whether the eye's visual pathway detects a light 6 dB brighter than that which could be detected by an eye of a healthy subject who is the same age. A total of 76 points of light are presented in the central and peripheral fields of each eye. Examiners were trained for a half day in the use of the Humphrey Field Analyzer. The training session covered calibration of the perimeter, the choice of the corrective lenses used for the test, and the explanation of the test to subjects. Examiners performed screening visual field tests on volunteers until they could be certified as proficient by the study coordinator or investigators.
A BVF for each participant was created by overlapping two 76-screening visual fields for each eye, using a method adapted from Esterman's BVF functional scoring algorithm. 9, 16 The total number of points missed out of the 96 possible points in the BVF was recorded. BVF loss was categorized into four groups: no loss (0 points missed), mild loss (1 to 9 points missed), moderate loss (10 to 19 points missed), and severe loss (20 or more points missed). 9 Distance visual acuity was measured in each eye separately with habitual correction under standard illumination using Bailey-Lovie charts, 17 which feature geometric progression in letter size from line to line. The number of letters seen correctly was recorded. Contrast sensitivity was also measured in each eye with habitual correction under standard illumination using the VCTS 6500 charts (Vistech Consultants, Inc., Dayton, Ohio), 18 which present a series of sine-wave gratings at calibrated levels of contrast at specific spatial frequencies (cycles per degree). The number of gratings seen correctly was recorded and converted to a contrast sensitivity score at each spatial frequency according to the manufacturer's manual.
Other measurements
We sought to incorporate in our analyses both vision-related and other clinical characteristics reported to be risk factors or confounders for fractures. As described in prior SOF publications, 5, 6, 9, [12] [13] [14] all risk factors and confounders were collected at V6 except for history of any fractures since age 50 which was obtained at Visit 1 on the original cohort and at V6 in the black cohort at V6 because V6 is their first (baseline) visit.
Statistical Analysis
The primary objective of the analysis was to determine the extent to which visual field loss was associated with risk of incident hip and non-spine/non-hip fractures in older white and African-American women. Visual acuity in the better-seeing eye was dichotomized into Snellen visual acuity levels of 20/40 or better versus worse than 20/40. Contrast sensitivity (CS) in the better-seeing eye at low spatial frequency (1.5 cycles/degree) was categorized into CS score of less than 25 versus 25 or greater. When information was not available for at least one eye at 1.5 cycles/degree, we used the contrast sensitivity values for 3 cycles/ degree. Because certain distributions were skewed, Spearman correlation coefficients were used to characterize associations among the continuous vision variables: BVF loss, visual acuity, and contrast sensitivity.
We used Cox proportional-hazards analysis to determine whether BVF loss was a risk factor for time until the occurrence of a fracture. We considered the following potential confounding variables: age, study site, race, self-rated health status, current smoker status, alcohol use, self-reported diabetes, self-reported hyperthyroidism, self-reported osteoporosis, current use of anticonvulsant drugs, current use of long-acting benzodiazepines, average grip strength, use arms to stand up, body mass index, depression, cognitive function, walking speed, falls in the past year (one or more falls within 12 months prior to the examination), hip bone mineral density, and history of any fractures since age 50. Separate models considered different subsets of potential confounders as described in further detail in the Results section.
We also evaluated interactions between BVF loss and age, as well as interactions between BVF loss and race. We calculated the percent attributable risk (i.e. the proportion of fractures among women who had BVF loss that is attributable to this loss, calculated using the formula 100 × (RR-1)/RR, where RR is the risk ratio estimate) and the population attributable risk percentage (i.e. the proportion of fractures among the total population that is attributable to BVF loss, calculated using the formula 100 × P(e) × (RR-1)/(1+P(e) × (RR-1)), where P(e) is the prevalence of severe BVF loss in the population). 19 To evaluate predictors of fractures, we used Akaike's information criterion (AIC) 20 to compare different models. Larger AIC values indicate the model with the better fit.
In secondary sensitivity analyses, BVF loss, visual acuity in the better eye, and CS at low spatial frequency in the better eye were analyzed as continuous variables in regression models adjusted for the same covariates as above. To control for skewness and extreme values, the continuous BVF loss variable was analyzed as the number of points lost up to 40 points, with any greater value fixed at 40 to improve linearity in a manner similar to rank transformations. The continuous visual acuity variables were analyzed as the number of letters read correctly, which is a logarithmic transformation of Snellen visual acuity. The continuous CS variables were analyzed as a logarithmic transformation of CS score at low frequency. All continuous vision variables were then standardized by dividing by their respective standard deviations (SD) after transformation, and the results were presented as risk ratios of incident fractures per one SD change in specific vision parameter.
All statistical analyses were performed using SAS version 9.1 software (SAS Institute Inc., Cary, NC). A p-value of < .05 was considered statistically significant.
RESULTS
The 4773 volunteers included in this analysis were slightly younger and had better self-rated health status, experienced less depression, and had better visual acuity in the better eye than the 709 women who were excluded. A total of 1,773 women (37%) had no BVF loss, 2,015 (42%) had mild BVF loss, 485 (10%) had moderate BVF loss, and 500 (11%) had severe BVF loss. The range of points lost across both eyes was from 0 to 87 with a mean of 6.4 (standard deviation [SD]=11.7). The Spearman correlation coefficients were -0.17 (p<0.0001) between BVF loss and visual acuity, -0.17 (p<0.0001) between BVF loss and contrast sensitivity, and 0.38 (p<0.0001) between visual acuity and contrast sensitivity. Table 1 Women with a first hip fracture missed a mean of 8.3 points (SD=13.5) on the BVF test, while women who did not have any fractures missed a mean of 6.1 points (SD=11.3) (p<0.0001). Figure 2 shows the Kaplan-Meier curves of time to hip fracture by the status of BVF loss. In analyses adjusted for age, race, study site, and cognitive function, women with severe BVF loss had a risk of hip fracture estimated to be 66% greater than that of women with no visual field loss (HR [hazards ratio]=1.66; 95% CI: 1.19-2.32) ( Table 2 ). The association between severe visual field loss and the risk of hip fracture was borderline significant in the fullyadjusted model (HR=1.37; 95% CI: 0.97-1.95) ( Table 2) and was not significant when hip bone mineral density was included in the fully-adjusted model (HR=1.24; 95% CI: 0.86-1.77).
Among the 3,869 women included in the analysis examining the association between visual field loss and risk of non-hip/non-spine fracture, 770 (19.9%) women experienced a nonspine/non-hip fracture during a mean of 8.0 years (SD=2.8) of follow-up. 1494 women without BVF loss had 307 (20.5%) non-spine/non-hip fractures (incidence=23.9 per 1000 person-years; 95% CI:21.3-26.7 per 1000 person-years); 1615 women with mild visual field loss had 285 (17.6%) non-spine/non-hip fractures (incidence=22.1 per 1000 person-years; 95% CI: 19.7-24.9 per 1000 person-years); 378 women with moderate visual field loss had 80 (21.2%) non-spine/non-hip fractures (incidence=29.0 per 1000 person-years; 95% CI: 23.3-36.1 per 1000 person-years); 382 with severe visual field loss had 98 (25.7%) nonspine/non-hip fractures (incidence=37.5 per 1000 person-years; 95% CI:30.7-45.7 per 1000 person-years). Women with at least one incident non-spine/non-hip fracture missed a mean of 7.3 points (SD=13.4) on the BVF test, while women who did not have any fractures missed a mean of 5.9 points (SD=10.8) (p=0.30). Women with severe BVF loss had roughly a 1.6-fold risk of a non-spine/non-hip fractures compared to women without any visual field loss in analyses adjusted for age, race, study site, and cognitive function (HR=1.59; 95% CI: 1.24-2.03) ( Table 3 ). This elevated risk remained significant in the fully-adjusted model (HR=1.46; 95% CI: 1.13-1.89) ( Table 3 ) and when hip bone mineral density (HR=1.44; 95% CI: 1.11-1.86) was included in the fully-adjusted model.
The number of incident hip fracture was not large enough for examining reliably the interaction effects in the hip fracture models, and we found no evidence of an interaction between age and visual field loss (p=0.48) and between race and visual field loss (p=0.15) in the non-spine/non-hip fracture models.
Visual acuity worse than 20/40 was not significantly associated with risk of hip fractures ( Table 2) but was associated with a 19% increased risk (HR=1.19; 95% CI: 1.00-1.41) of non-spine/non-hip fractures when the model was adjusted for age, race, study site, and cognitive function (Table 3 ). Women with poor contrast sensitivity (<25 CS score) had a higher risk of non-spine/non-hip fracture in the fully-adjusted model ( Table 3) which remained present when hip bone mineral density was included in the model (HR=1.27; 95% CI: 1.09-1.49).
Using the estimate of 1.37 in the fully adjusted model as the relative risk of hip fracture for severe BVF loss compared to no loss, the percent attributable risk for severe BVF loss was 27%. Assuming that 10% of older women had severe loss similar to the SOF population, the population attributable risk percentage for severe BVF loss for hip fracture was 3.7%. Using the estimates of 1.46 for severe BVF loss in the fully adjusted models, for non-spine/non-hip fractures, the percent attributable risk for severe BVF loss was 31.5%, and the population attributable risk percentage was 4.6% (assuming that 10% of older women have severe BVF loss).
In secondary sensitivity analyses where continuous vision variables were used, women who missed more points on the BVF had a higher risk of hip fractures (HR=1.11 per SD; 95% CI: 1.01-1.21) and non-spine/non-hip fractures (HR=1.18 per SD; 95% CI: 1.10-1.27). Women who recognized more letters (visual acuity was better) with the better-seeing eye had less risk of hip (HR=0.90 per SD; 95% CI: 0.82-0.99) and non-spine/non-hip fractures (HR=0.87 per SD; 95% CI: 0.81-0.94). Women with higher contrast sensitivity scores in the better eye had less risk of non-spine/non-hip fractures (HR=0.87 per SD; 95% CI: 0.80-0.93) and no risk of hip fractures (HR=0.98 per SD; 95% CI: 0.89-1.09).
The test for trend where risk was posited to increase linearly across severity categories of BVF loss was statistically significant for non-spine/non-hip fractures (trend p<0.0001) and was of borderline significance for hip fractures (trend p= 0.052), after adjustment for age, site, race, and cognitive function. Using AIC values, the inclusion of BVF loss in the fullyadjusted models for hip and non-spine/non-hip fractures improved model fit more than the inclusion of visual acuity or contrast sensitivity. The inclusion of hip bone mineral density in the fully-adjusted models decreased the AIC scores of all the models, suggesting poorer predictive ability. The highest AIC values were obtained in the models adjusted for age, race, study site, and cognitive function.
DISCUSSION
Older women with BVF loss have an increase in the risk of subsequent hip and non-spine/ non-hip fractures. The association between visual field loss and risk of fracture was graded in nature. We estimated that 3.7% of hip fractures and 4.6% of non-spine/non-hip fractures were attributable to severe visual field loss using standard epidemiological estimation procedures.
Visual field loss can be induced by ocular diseases, such as glaucoma, cataracts and retinal disease, 21 by a tumor 22 or vascular occlusion 8 along the cerebral visual pathway, or by cognitive factors such as inattention during the visual field test. 21 The leading cause of visual field loss in persons 55 years or older is glaucoma, 8 which is the second leading cause of preventable blindness worldwide. 23 Since vision loss from glaucoma can be prevented or slowed down with treatment 24 and half or more of individuals with glaucoma in the population are undiagnosed, 25, 26 screening tests can identify not only patients at increased risk for subsequent fractures but also patients who have potentially blinding yet treatable ocular diseases.
Technicians or nurses in the offices of clinicians can screen for visual field loss with a suprathreshold screening test as was used in this study. The test takes 4 minutes per subject and is straightforward to administer. Fewer than 13% of subjects visiting the clinic were unable to complete the visual field testing in our study. The sensitivity and specificity of suprathreshold testing was 87% and 89%, respectively, in a study evaluating the use of suprathreshold testing in screening for neuro-ophthalmic diseases such as glaucoma. 27 Once visual field loss is detected on a screening test, subjects should be referred for an eye evaluation by an eye doctor if the visual field loss is present on repeat visual field testing. 21 Prior studies have not evaluated whether BVF loss is associated with an increased risk of fractures in older women, but have evaluated the association between visual field loss in at least one eye and fractures among younger white subjects. 8, 10, 11 Both studies had younger cohorts and did not have as many incident fractures as SOF. Their findings contrast with those of our study that suggest that the greater risk of hip and non-spine/non-hip fractures in older women secondary to visual field loss persists for at least 8 years after visual field testing.
In a prior SOF manuscript, 5 we have reported that there is increased risk of hip fractures in women with decreased contrast sensitivity while reductions of visual acuity were not associated with increased risk of fractures. In this study we report that contrast sensitivity is not as strong of a predictor for hip fractures as BVF loss. These results are not surprising since cataracts, [28] [29] [30] glaucoma, 29, 31 and AMD 29,32 may cause both decreased contrast sensitivity and visual field loss.
Strengths of our study include a large sample size, a long follow-up period, a well-defined cohort, radiographically adjudicated fractures, assessment of different vision components, and the utilization of standardized protocols for all measurements. A potential limitation of this study is that we calculated the BVF loss using the Esterman's BVF scoring algorithm rather than directly measuring visual fields with both eyes. This method of assessing BVFs is accepted in vision research and is consistent with the results found when an Esterman BVF test is performed. [33] [34] [35] Our study population was comprised of older volunteer women initially living in communities; therefore, our results might not apply to other populations such as men, younger women, or those with poorer health or living in institutions. It is possible that in a less healthy population, women may have even greater risk of fractures than we reported, especially since the women in our study are survivors and most likely are healthier than women who did not continue in SOF because of death or illness. In addition, the women in this study were highly motivated. Fewer than 13% of the women in SOF were excluded from this analysis because of either inability to perform visual fields or unreliable visual fields. We excluded women who participated only in home visits from our analyses. Their visual field loss could not be assessed since visual field testing cannot be performed in the home. Women participating only in home visits were slightly older and had worse self-rated health status. The women excluded from the analysis may be more likely to be immobile and thus may have lower risks of fracture; alternatively, excluded women may be at greater risk of fracture because they are likely to have worse vision than the women whose visual fields were assessed.
A limitation of our study is that we did not assess spine fractures at V6, and to diagnose radiographic spine fractures both baseline and follow-up spine films are needed. In addition, while we adjusted for cognitive impairment using the Mini Mental State Examination (MMSE), the MMSE may not detect all types of dementia that may be associated with the presence of visual field loss. Another limitation of this study is that all risk factors and confounders were assessed at V6 and may have changed over time. This is especially true for the assessment of BVF loss, which was only done at V6. Continued visual field loss may be detected a mean of 7.5 years after the first glaucomatous visual field loss is detected. 36 Since visual field loss is an independent risk factor for subsequent fractures, clinicians are advised to evaluate patients' vision when they report recurrent falling. 37 This recommendation, however, does not specify a method for evaluating vision among the multitude of tests that could be performed. Our data suggest that future guidelines for the care of older patients should consider recommending evaluations of the visual fields in patients at heightened risk of fractures by recommending that clinicians either refer their patients who are recurrent fallers for visual field loss assessment or screen for visual field loss themselves using suprathreshold tests such as was done in SOF. Potential areas for future research include study of interventions to prevent fractures by managing visual field loss or through mobility training as well as further research on the impact of visual field loss on ability to function and quality of life. 
